Search
for
Sort by
Research 871–900 of 1000+
- Use of virtual reality during scalp injections: A randomized interventional crossover study
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Regenerative Therapies for Cosmetic Dermatology for Patients with Diabetes Mellitus: Skin Aging, Aesthetic Concerns, and Evidence-Based Best Practices
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- The hair follicle as a neuro-immuno-endocrine organ: Implications in hair disorders and regenerative therapies
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Lifestyle interventions in dermatology
- Time of onset and duration of post-COVID-19 acute telogen effluvium
- What does acne genetics teach us about disease pathogenesis?
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- The Dermatologic Care Needs of a Rural Community in South Florida
- Topical imiquimod—Be aware of the unexpected
- Platelet-Rich Plasma in Dermatology: New Insights on the Cellular Mechanism of Skin Repair and Regeneration
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- Terapias regenerativas en dermatología y medicina estética: plasma rico en plaquetas y células madre
- Cosmetic and Dermatological Properties of Olive Oil Byproduct-Supplemented Skin and Hair Care Products
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Safety and efficacy of tavaborole (AN2690), a novel boron-based molecule, in 3 phase II trials for the topical treatment of toenail onychomycosis
- Abstracts Pt.30
- The psychological effects of androgenetic alopecia in men
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- The role of PPAR<i>γ</i>-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Efficacy and safety of mycophenolate mofetil for lichen planopilaris
- Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Profiling the Response of Human Hair Follicles to Ultraviolet Radiation
- Treatment of Generalized Lichen Planus With Alefacept